Collage photo of Nir Hacohen and Susan Klaeger
Mar 11, 2025, 08:25
CRI Scientists Nir Hacohen and Susan Klaeger Contribute to Developing Effective Kidney Cancer Vaccine
Cancer Research Institute (CRI) shared a post on LinkedIn:
“Researchers including CRI Scientific Advisory Council member Dr. Nir Hacohen and former CRI Fellow Dr. Susan Klaeger of Broad Institute of MIT and Harvard recently published ‘promising results from a clinical trial testing the effectiveness of a new cancer vaccine that treats patients with kidney cancer,’ Yale Daily News describes.
‘The team’s vaccine represents a recent shift to more targeted cancer therapies than general treatments like surgery, radiation and chemotherapy that tend to prolong life in advanced cancer patients but do not usually elicit long-term responses.’
Explore.”
More posts featuring Cancer Research Institute.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Apr 19, 2025, 19:36
Apr 19, 2025, 19:17
Apr 19, 2025, 19:01
Apr 19, 2025, 18:42
Apr 19, 2025, 18:29
Apr 19, 2025, 17:53
Apr 19, 2025, 17:17